Who is sponsoring NCT05780086?

NCT05780086 is sponsored by Instituto Mexicano del Seguro Social.

What drugs are being tested in NCT05780086?

Interventions in NCT05780086: 30% icodextrin and 10% dextrose.

What condition does NCT05780086 study?

NCT05780086 studies Chronic Kidney Diseases.

Is NCT05780086 still recruiting?

NCT05780086 is currently status unknown. Last updated 28 March 2023.

Last reviewed 2023-03-28 · How we verify

NCT05780086

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution

Status unknown Phase 1 Last updated 28 March 2023

What this trial tests

Phase 1 trial testing 30% icodextrin and 10% dextrose in Chronic Kidney Diseases in 10 participants. Status unknown.

Timeline

3 February 2023

Primary endpoint
30 August 2023

30 December 2023

Quick facts

Lead sponsor	Instituto Mexicano del Seguro Social
Phase	Phase 1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	3 February 2023
Primary completion	30 August 2023
Estimated completion	30 December 2023
Sites	1 location across Mexico

Drugs / interventions tested

30% icodextrin and 10% dextrose — full drug profile →

Conditions studied

Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →

Sponsor

Instituto Mexicano del Seguro Social — full company profile →

Who can join

18 and older, any sex, with Chronic Kidney Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the safety and tolerability profile of a dwell time (bath) of 24 hours using a 500 ml sodium-free peritoneal dialysis solution based on 30% icodextrin and 10% dextrose in patients with chronic kidney failure undergoing peritoneal dialysis

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Development of a Novel Intraperitoneal Icodextrin/Dextrose Solution for Enhanced Sodium Removal.
Asher JL, Ivey-Miranda JB, Maulion C, Cox ZL, et al · · 2025 · cited 4× · PMID 39790231 · DOI 10.1016/j.xkme.2024.100938

Verify or expand the search:

Other recruiting trials for Chronic Kidney Diseases

Currently open trials in the same condition.

NCT06593392 — Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus · Phase 2 · recruiting
NCT07358572 — Eye-Brain-Kidney in CKD · recruiting
NCT06463483 — Automated Insulin Delivery in Adults With Advanced Kidney Disease · NA · recruiting
NCT06927024 — Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD) · NA · recruiting
NCT07115953 — Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension · NA · recruiting

Other Instituto Mexicano del Seguro Social trials

Trials by the same sponsor.

NCT07536009 — "Effectiveness of a Telerehabilitation Program Versus a Conventional Rehabilitation Program in Patients With Subacromial · NA · not yet recruiting
NCT06632184 — Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy · Phase 4 · active not recruiting
NCT07073846 — Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery. · Phase 4 · recruiting
NCT07406971 — Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke · Phase 2 · recruiting
NCT07134504 — Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05780086 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Mexicano del Seguro Social
Last refreshed: 28 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05780086.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing